About
Technology
Issues
FAQ
Links
Official Page
Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.